This article identifies stocks experiencing significant price movements, categorizing them into "gap up" and "gap down" stocks. It lists specific companies with their respective percentage changes and provides brief comments regarding recent performance or news. The article serves as a quick overview of notable stock movements during the trading session.

Best Buy Co., Inc. (NYSE:BBY) has received an average "Hold" rating from brokerages, with a consensus one-year price target of $79.05. The company recently surpassed quarterly earnings and revenue expectations, reporting $1.28 EPS on $8.94 billion in revenue, and announced a quarterly dividend of $0.96 per share. Despite positive Q1 results driven by demand for AI laptops and other tech, recent insider stock sales, including by the CFO and CEO, may draw investor scrutiny.

Analysts have given KLA Corporation (NASDAQ:KLAC) a consensus rating of "Moderate Buy," with an average 12-month price target of $1,842.18. The semiconductor equipment maker recently exceeded earnings and revenue expectations, reported strong Q4 2026 guidance, and announced a 10-for-1 stock split and an increased quarterly dividend. The company also has a $7 billion share buyback authorization.

KT announced it is upgrading its zero-trust security strategy to implement constant prevention and preemptive response systems across its entire enterprise. The company is moving from a reactive approach to a proactive one by introducing behavior-based detection systems and enhancing microsegmentation to limit damage spread during breaches. KT plans to apply these technologies across its work environment this year following operational stability and policy verification.

This GuruFocus article provides a detailed financial overview of Tyson Foods Inc (XTER:TF7A), including its current stock price (€54.68), market capitalization (€17.81B), and various financial ratios like P/E (44.79) and P/B (1.11). It highlights two severe warning signs detected by GuruFocus for TF7A and offers a business description, financial strength, growth, profitability, and valuation ranks, along with a calendar of upcoming events and recent news.

Intellia Therapeutics (NTLA) has seen its updated price target slightly lowered to $26.63, reflecting a mix of analyst optimism and caution regarding its future growth, despite positive Phase 3 trial results for its hereditary angioedema (HAE) treatment, lonvoguran ziclumeran. The company has initiated an FDA submission for lonvo z and had clinical holds lifted on another Phase 3 candidate, nexiguran ziclumeran, suggesting potential for future upside driven by regulatory progress and pipeline development. However, analysts are balancing these positive developments with execution risks and market selectivity, leading to a constrained consolidated price target.

OUTFRONT Media (NYSE:OUT) has refinanced its debt by issuing US$500 million of new senior notes due 2034 with a higher 6.000% coupon, in order to redeem older notes due 2027. This move extends their debt maturity profile but increases interest expenses. Additionally, the company filed a shelf registration allowing for the issuance of common stock for an employee stock ownership plan, which could lead to share dilution but aligns employee interests.

Duke Energy has secured a grant of up to $61.8 million from the U.S. Department of Energy to enhance the reliability of its coal-fired power plants in Kentucky and North Carolina. The East Bend Power Station in Kentucky is allocated up to $33.4 million, while Roxboro Station in North Carolina will receive up to $28.4 million for critical component refurbishment. These investments aim to reduce costs for customers and strengthen the energy grid amidst growing demand.

Gilead Sciences and Lakefront Biotherapeutics have acquired Ouro Medicines to enhance their inflammation and immunology pipelines. The acquisition centers on gamgertamig (OM336), a clinical-stage T cell engager for severe autoimmune diseases. Lakefront will manage early-stage clinical studies, while Gilead leads late-stage development and holds global commercialization rights, with Lakefront receiving royalties and three preclinical autoimmune programs.

Mid-America Apartment Communities (MAA) recently declared a dividend and released an updated investor presentation, reaffirming its full-year guidance and Q1 2026 earnings beat. The article suggests these communications provide insight into MAA's strategy for balancing rent growth and development against market conditions in the Sunbelt. While the company's long-term appeal in Sunbelt rental housing remains a key driver, near-term challenges such as elevated new supply in markets like Austin and Phoenix present risks that investors should consider alongside the projected fair value and dividend stability.